10
10
1.0

速度
2.0
1.8
1.5
1.0
0.5
速度
2.0
1.8
1.5
1.0
0.5

CMIC HOLDINGS Co., Ltd.

Overview of Financial Results for FY2019

November 14, 2019

Kazuo Nakamura
Chairman and Chief Executive Officer

Keiko Oishi
President and Chief Operating Officer

Wataru Mochizuki
Chief Financial Officer

SLIDE OFF

  • Overview of Financial Results for FY2019

  • FY19 Financial highlights (October 1, 2018-September 30, 2019)

    Wataru Mochizuki, CFO

  • CMIC Overview

  • CMIC's unique business model (PVC)

  • Comprehensively support the value chains of pharmaceutical companies

  • CMIC Group Global Coverage

  • Business segments and group companies

  • Main initiatives of the current term

  • Consolidated income statement (overview)

  • Breakdown of Non-operating income and expenses / Extraordinary income and losses / Income taxes

  • Sales & Operating income by segment

  • Orders received / Backlog

  • Trend in consolidated Sales & Operating income

  • Contract Research Organization (CRO) Business

  • Contract Development Manufacturing Organization (CDMO) Business

  • Contract Sales Organization (CSO) Business

  • Healthcare Business

  • Innovative Pharma Model（ IPM ）Business

  • Balance sheet (assets)

  • Balance sheet (liabilities and net assets)

  • Cash Flows

  • Forecast for FY ending Sep. 2020

  • Forecast for FY ending Sep. 2020

  • Forecast for FY ending Sep. 2020 (by segment)

  • Mid-term Management Plan (FY19-21) Progress Updates

    Keiko Oishi, COO

  • Mid-term Plan (FY19-21）　　（Announced in November 2018)

  • Acceleration of PVC model and IPM solutions

  • Promotion of PVC projects

  • Understanding the CRO landscape

  • CRO business activities

  • CDMO business activities and CMIC Group Manufacturing Sites

  • CSO business activities

  • Healthcare business initiatives

  • To accelerate healthcare business transformation

  • IPM business activities

  • Promoting CRO Globalization

  • JAPAN Operations

  • Outside JAPAN Operations

  • Mid-term Management Plan Updates

  • Healthcare Revolution

    Kazuo Nakamura, CEO

  • “Japanese paradox” and their longevity

  • Japan’s Mean Life Expectancy：From the bottom to the top

  • G7 Countries Median Life Expectancy（2050）

  • From CRO through PVC to Healthcare Value Creator

  • The CMIC Way

  • Actions required for CRO

  • The CMIC Way

  • Definition of the new healthcare system

  • SelCheck®

  • SelCheck®

  • SelCheck®

  • “harmo” business

  • Value of harmo service

  • Future outlook

  • Concept of using harmo as PHR

  • Joint research to improve Wellbeing

  • CMIC’S CREED

  • CMIC’S CREED

facebook twitter